Prime Medicine, Inc. (PRME:NASDAQ) closed at $3.55 on November 20, 2026, down 7.55% on the day. The stock trades 39.9% below its 52-week high of $5.91 and 33.0% above its 52-week low of $2.67. Over the past year, it lost 6.3%. Prime Medicine, Inc. is part of the Health Care sector.
In 252 trading sessions since November 20, 2025, PRME closed higher on 112 days (44%). Its best day was October 28, 2026 (+23.22%) and its worst was June 5, 2026 (-11.82%). The stock moved 10% or more in a single session 23 times. It opened at least 5% above the previous day's high 5 times.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs.
Find more stocks like PRME with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.